Trials / Unknown
UnknownNCT02312362
High Frequency Deep Sclerotomy (HFDS) ab Interno a Combination Surgical Intervention Using Cataract Surgery to Lower IOP
HFDS ab Interno - to Compare Intraocular Pressure (IOP) Lowering Effect of Combined High Frequency Deep Sclerotomy ab Interno (HFDS ab Interno) With Phacoemulsification and Phacoemulsification Alone, in Primary Open Angle Glaucoma Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- Sponsor
- Oertli Instrumente AG · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Objective: To compare intraocular pressure lowering effect of combined sclerotomy ab interno with phacoemulsification and phacoemulsification alone, in primary or secondary open angle glaucoma patients. Study design: Prospective, randomized, case- control interventional surgical trial
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Combined sclerotomy ab interno and phaco | |
| PROCEDURE | Phacoemulsification with IOL implantation |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2015-06-01
- Completion
- 2016-12-01
- First posted
- 2014-12-09
- Last updated
- 2014-12-09
Locations
5 sites across 4 countries: Egypt, Germany, India, Switzerland
Source: ClinicalTrials.gov record NCT02312362. Inclusion in this directory is not an endorsement.